TAKEDA PHARM.CO.LTD.TAKEDA PHARM.CO.LTD.TAKEDA PHARM.CO.LTD.

TAKEDA PHARM.CO.LTD.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪40.61 B‬EUR
1.15EUR
‪882.16 M‬EUR
‪26.11 B‬EUR
‪1.54 B‬
Beta (1Y)
0.51
Employees (FY)
‪49.28 K‬
Change (1Y)
+186 +0.38%
Revenue / Employee (1Y)
‪571.63 K‬EUR
Net income / Employee (1Y)
‪19.31 K‬EUR

About TAKEDA PHARMACEUTICAL CO LTD


CEO
Christophe Weber
Headquarters
Osaka
Website
Founded
1781
ISIN
JP3463000004
FIGI
BBG000BYJS73
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
TKPH5841810
Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064
Yield to maturity
5.66%
Maturity date
Jul 5, 2064
B
TKPH4369980
Baxalta Incorporated 5.25% 23-JUN-2045
Yield to maturity
5.63%
Maturity date
Jun 23, 2045
TKPH5841809
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054
Yield to maturity
5.56%
Maturity date
Jul 5, 2054
TKPH5841808
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044
Yield to maturity
5.44%
Maturity date
Jul 5, 2044
TKPH5010046
Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040
Yield to maturity
5.40%
Maturity date
Jul 9, 2040
TKPH5010047
Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050
Yield to maturity
5.15%
Maturity date
Jul 9, 2050
TKPH5841807
Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034
Yield to maturity
5.12%
Maturity date
Jul 5, 2034
TKPH5010048
Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060
Yield to maturity
5.12%
Maturity date
Jul 9, 2060
TKPH5010045
Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030
Yield to maturity
4.74%
Maturity date
Mar 31, 2030
TKPH4770188
Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028
Yield to maturity
4.71%
Maturity date
Nov 26, 2028
S
US82481LAD1
SHIRE ACQUIST.I.IE 16/26
Yield to maturity
4.59%
Maturity date
Sep 23, 2026

Explore more bonds 

Frequently Asked Questions


The current price of TKD is 25.61 EUR — it has increased by 0.63% in the past 24 hours. Watch TAKEDA PHARM.CO.LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange TAKEDA PHARM.CO.LTD. stocks are traded under the ticker TKD.
TKD stock has fallen by −0.27% compared to the previous week, the month change is a −0.54% fall, over the last year TAKEDA PHARM.CO.LTD. has showed a −0.08% decrease.
We've gathered analysts' opinions on TAKEDA PHARM.CO.LTD. future price: according to them, TKD price has a max estimate of 35.70 EUR and a min estimate of 25.42 EUR. Watch TKD chart and read a more detailed TAKEDA PHARM.CO.LTD. stock forecast: see what analysts think of TAKEDA PHARM.CO.LTD. and suggest that you do with its stocks.
TKD reached its all-time high on Mar 7, 2006 with the price of 416.21 EUR, and its all-time low was 22.00 EUR and was reached on Mar 9, 2009. View more price dynamics on TKD chart.
See other stocks reaching their highest and lowest prices.
TKD stock is 0.63% volatile and has beta coefficient of 0.51. Track TAKEDA PHARM.CO.LTD. stock price on the chart and check out the list of the most volatile stocks — is TAKEDA PHARM.CO.LTD. there?
Today TAKEDA PHARM.CO.LTD. has the market capitalization of ‪40.47 B‬, it has decreased by −0.20% over the last week.
Yes, you can track TAKEDA PHARM.CO.LTD. financials in yearly and quarterly reports right on TradingView.
TAKEDA PHARM.CO.LTD. is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
TKD earnings for the last quarter are 0.36 EUR per share, whereas the estimation was 0.23 EUR resulting in a 57.13% surprise. The estimated earnings for the next quarter are 0.20 EUR per share. See more details about TAKEDA PHARM.CO.LTD. earnings.
TAKEDA PHARM.CO.LTD. revenue for the last quarter amounts to ‪7.35 B‬ EUR, despite the estimated figure of ‪6.80 B‬ EUR. In the next quarter, revenue is expected to reach ‪7.06 B‬ EUR.
TKD net income for the last quarter is ‪575.14 M‬ EUR, while the quarter before that showed ‪552.39 M‬ EUR of net income which accounts for 4.12% change. Track more TAKEDA PHARM.CO.LTD. financial stats to get the full picture.
TAKEDA PHARM.CO.LTD. dividend yield was 4.49% in 2023, and payout ratio reached 204.15%. The year before the numbers were 4.14% and 88.11% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 10, 2024, the company has ‪49.28 K‬ employees. See our rating of the largest employees — is TAKEDA PHARM.CO.LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TAKEDA PHARM.CO.LTD. EBITDA is ‪8.55 B‬ EUR, and current EBITDA margin is 29.51%. See more stats in TAKEDA PHARM.CO.LTD. financial statements.
Like other stocks, TKD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TAKEDA PHARM.CO.LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TAKEDA PHARM.CO.LTD. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TAKEDA PHARM.CO.LTD. stock shows the sell signal. See more of TAKEDA PHARM.CO.LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.